BC Innovations | May 26, 2011
Distillery Therapeutics

Indication: Neurology

This week in therapeutics Neurology Pain EPH receptor B1 (EPHB1) Rat studies suggest inhibiting EPHB1 signaling could help treat bone cancer pain and prevent morphine tolerance. In a rat model of bone cancer pain, spinal...
BC Innovations | May 26, 2011
Distillery Therapeutics

Indication: Autoimmune disease

This week in therapeutics Autoimmune disease Autoimmune disease CD28; inducible T cell co-stimulator ligand (ICOSLG; B7-H2) In vitro and cell culture studies suggest inhibiting interactions between B7-H2 and CD28 could help treat autoimmune disease. An...
Items per page:
1 - 2 of 2